Delivery Order SPE2DB22D1106-SPE2DB24FFMT0

Award Date 9/12/24
Potential Completion Date 9/13/24
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $5,273.63 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of a pharmaceutical product, Fluticasone-Salmeterol 115-21 12GM. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities, including prescription drugs and medical...
The U.S. Defense Logistics Agency (DLA) awarded a $7,648.67 firm fixed-price delivery order to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of Fluticasone-Salmeterol 115-21 12GM pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025 between Amerisourcebergen and DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of essential...
The U.S. Defense Logistics Agency (DLA) awarded a $5,454.01 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone-Salmeterol 230-21 12GM, a prescription medication product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of medical commodities to support...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,841.64 firm fixed-price delivery order is for the supply of fluticasone-salmeterol 115-21 12GM, a respiratory medication. The contract has an ultimate completion date of February 4, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,104.06 delivery order is for the supply of Fluticasone-Salmeterol 45-21 12GM, a medication used in the treatment of respiratory conditions. The contract has an ultimate completion date of October 17, 2024 and is a Firm Fixed Price agreement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,029.20 firm fixed price delivery order is for fluticasone-salmeterol 115-21 12GM, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,364.06 firm fixed-price contract is for the supply of fluticasone-salmeterol 115-21 12GM, a respiratory medication, through January 31, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $1,841.64 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide fluticasone-salmeterol 115-21 12GM medical products. This order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a primary vehicle for the company to supply a wide range of pharmaceutical and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,465.56 firm fixed-price delivery order is for the supply of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product, with a completion date of March 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of fluticasone-salmeterol 115-21 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,061.44 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of July 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFMT0
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $20,264.02 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of fluticasone-salmeterol 115-21 12GM, a respiratory medication. The contract has an ultimate completion date of September 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. AmerisourceBergen has also been awarded a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for the supply of medical products and prescription drugs. The contract award does not have a set-aside designation.

Generated 12/12/24, 9:22 AM